We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Owning physical drugstores is not the cash cow it once was
New three-year contract in place if UK drugmaker continues to manufacture the jab
Some managers expect cheaper valuations will fuel M&A activity
Change would incorporate genetic material from fast-spreading strain in new boosters
The global south has once again been abandoned in its quest for vaccines
Washington seeks to expand domestic production of crucial component of mRNA vaccines
Short break in immune suppression treatment improves antibody production after vaccination while doing little harm
New vaccine candidates significantly outperform existing Covid jabs at targeting the most prevalent strain
Pharma companies are hoping to catch up with rivals as they report promising trial results for jab
Javid says he asked officials to revise previous plans that would exclude under-65s
UK health agency investigating possibility of community transmission says risk to public ‘extremely low’
US biotech group says shot targeting both first strain and Omicron could help avert ‘large rise’ in cases
Government seeks to secure domestic jab supply and prepare for future pandemics in deal with Boston biotech
Early-stage drugmakers face difficult decisions as public markets turn hostile
This legal manoeuvre is setting a new precedent for corporations to evade accountability in America
US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme
Children as young as six months old can begin receiving Pfizer or Moderna vaccines as soon as Monday
‘Time is ticking’ as studies suggest original Omicron jabs may not offer strong protection against sub-variants
Recommendation by health agency advisory group marks shift in thinking of global health authorities
Cancer Research UK will eventually spend £295mn with National Cancer Institute on projects to understand and prevent tumour growth
Only 1 per cent of the 10bn jabs delivered so far have been in low-income countries
Lawyer Olga Gurgula drafted a law to enable the local production of generic drugs for civilians and the military
US prepares to roll out jabs to last age group without access once regulatory approval is received
White House drug tsar says marijuana legalisation and safe injection sites will also be reviewed
Hedgie turned medical researcher notches up a big win
International Edition
